Summit Partners to invest in Dreampath Diagnostics.

Summit Partners, a private equity firm, agreed to invest in Dreampath Diagnostics, a diagnostic technology company. Financial terms were not disclosed. “Pathology labs are a critical part of the global healthcare ecosystem, yet many still rely on manual, error-prone processes for sample archiving and retrieval. Our mission is to improve the efficiency and accuracy of these workflows through automation and digital traceability, allowing labs to provide patients with faster and safer diagnostics. We’re proud to partner with Summit to help us scale our impact and reach more patients around the world,” Pablo Jordan, Dreampath Diagnostics CEO and Co-Founder.